David A. Tice

6.6k citations

97 papers · 4.7k indexed · 1 hit paper · h-index 38

Impact in

Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
Oncology top 2%
- HER2/EGFR in Cancer Research

Papers in

Immunology and Allergy 7
- Cell Adhesion Molecules Research 7
Cardiology and Cardiovascular Medicine 22
- Cardiac Valve Diseases and Treatments 13

Co-authors: Sarah J. Parsons Jacqueline S. Biscardi Frank C. Spencer George E. Reed Ming‐Chei Maa Michael Cox Roy H. Clauss George E. Green
Journals: Cancer Research (12 papers)Journal of Thoracic and Cardiovascular Surgery (11 papers)Journal of Biological Chemistry (6 papers)Circulation (5 papers)Molecular Cancer Therapeutics (5 papers)
Partner nations: United States South Korea Brazil

In The Last Decade

David A. Tice

95 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function 1999 · 554 citations

Peers

Countries citing papers authored by David A. Tice

Since Specialization

Citations

This map shows the geographic impact of David A. Tice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Tice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Tice more than expected).

Fields of papers citing papers by David A. Tice

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Tice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Tice. The network helps show where David A. Tice may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Tice, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Tice Line = papers co-authored together David A. Tice links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Controlling CAR-T cell activity and specificity with synthetic SparX adapters Molecular Therapy ·Justin P. Edwards, Jeffrey S. Swers, Janine M. Buonato, Liubov Zaritskaya, Chaofeng Mu, Ankit Gupta, Sigal Shachar, David W. LaFleur, Laura K. Richman, David A. Tice, David M. Hilbert	2024	6
2	Preclinical Efficacy of BCMA-Directed CAR T Cells Incorporating a Novel D Domain Antigen Recognition Domain Molecular Cancer Therapeutics ·Janine M. Buonato, Justin P. Edwards, Liubov Zaritskaya, Hasalanka S Senarathna, Ankit Gupta, David W. LaFleur, David A. Tice, Laura K. Richman, David M. Hilbert	2022	16
3	MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer Breast Cancer Research ·Yoshimi Endo Greer, Samuel F. Gilbert, Brunilde Gril, Rajesh Narwal, Danielle L. Brooks, David A. Tice, Patricia S. Steeg, Stanley Lipkowitz	2019	48
4	Improved Therapeutic Window in BRCA -mutant Tumors with Antibody-linked Pyrrolobenzodiazepine Dimers with and without PARP Inhibition Molecular Cancer Therapeutics ·Haihong Zhong, Chen Cui, Ravinder Tammali, Shannon Breen, Minhong Su, Christine Fazenbaker, Éles László, James Conway, Brandon W. Higgs, Nicholas Holoweckyj, Rajiv Raja, Jay Harper, Andrew J. Pierce, Ronald Herbst, David A. Tice	2018	12
5	SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads Clinical Cancer Research ·Krista Kinneer, John Meekin, Arnaud Tiberghien, Yu‐Tzu Tai, Sandrina Phipps, Christine Mione Kiefer, Marlon C. Rebelatto, Nazzareno Dimasi, Alyssa Moriarty, Kyriakos P. Papadopoulos, Sriram Sridhar, Stephen J. Gregson, Michael J. Wick, Luke A. Masterson, Kenneth C. Anderson, Ronald Herbst, Philip W. Howard, David A. Tice	2018	58
6	Discovery and Development of MEDI7247, a Novel Pyrrolobenzodiazepine (PBD)-Based Antibody Drug Conjugate Targeting ASCT2, for Treating Hematological Cancers Blood ·Nabendu Pore, Kevin Schifferli, Noel R. Monks, Ravinder Tammali, M. Jack Borrok, Elaine M. Hurt, Margaret E. McDermott-Kubeczko, Marlon C. Rebelatto, Danielle M. Townsley, Mary Jane Hinrichs, Rakesh Dixit, Steven Coats, Ronald Herbst, David A. Tice	2018	7
7	Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging Agent Clinical Cancer Research ·Bangwen Xie, Michal R. Tomaszewski, André Neves, Susana R�os, De‐En Hu, Sarah McGuire, Stefanie Mullins, David A. Tice, Richard C.A. Sainson, Sarah E. Bohndiek, Robert W. Wilkinson, Kevin M. Brindle	2017	24
8	A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors Cancer Research ·Haihong Zhong, April Davis, Maria Ouzounova, Rosa A. Carrasco, Cui Chen, Shannon Breen, Yong S. Chang, Jiaqi Huang, Zheng Liu, Yihong Yao, Elaine M. Hurt, Jacques Moisan, Michael Fung, David A. Tice, Shawn G. Clouthier, Zhan Xiao, Max S. Wicha, Hasan Körkaya, Robert E. Hollingsworth	2016	40
9	5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma Clinical Cancer Research ·Samuel A. Kerk, Figueiredo Geisa Fantini de, Alexander T. Pearson, Kristy A. Warner, Zhaocheng Zhang, Felipe Nör, Vivian Petersen Wagner, Pablo Agustín Vargas, Max S. Wicha, Elaine M. Hurt, Robert E. Hollingsworth, David A. Tice, Jacques E. Nör	2016	40
10	A Potent HER3 Monoclonal Antibody That Blocks Both Ligand-Dependent and -Independent Activities: Differential Impacts of PTEN Status on Tumor Response Molecular Cancer Therapeutics ·Zhan Xiao, Rosa A. Carrasco, Kevin Schifferli, Krista Kinneer, Ravinder Tammali, Hong Chen, Lexuan Sun, Leslie Wetzel, Chunning Yang, Partha S. Chowdhury, Ping Tsui, Philipp Steiner, Bahija Jallal, Ronald Herbst, Robert E. Hollingsworth, David A. Tice	2016	27
11	HER2 drives Mucin-like 1 to control proliferation in breast cancer cells Oncogene ·Sarah J. Conley, Emily E. Bosco, David A. Tice, Robert E. Hollingsworth, Roy S. Herbst, Xiao Zhang	2016	31
12	Multivalent Scaffold Proteins as Superagonists of TRAIL Receptor 2–Induced Apoptosis Molecular Cancer Therapeutics ·常幸石井, 冉洁, Lin Wang, Hui Feng, Kristen Lekstrom, Rosa A. Carrasco, Zhan Xiao, Ivan Inigo, Ching Ching Leow, Herren Wu, David A. Tice, Manuel Baca	2013	43
13	Activation of the Wnt Pathway Interferes with Serum Response Element-driven Transcription of Immediate Early Genes Journal of Biological Chemistry ·David A. Tice, Irina Soloviev, Paul Polakis	2002	50
14	Src family kinases and HER2 interactions in human breast cancer cell growth and survival Oncogene ·Rima Melini, Jacqueline S. Biscardi, Louisa Widjaja, David A. Tice, Kilder Henrique Zander, Sarah J. Parsons	2001	154
15	Misplaced Greenfield Filter: Diagnosis by Transesophageal Echocardiography Journal of the American Society of Echocardiography ·U Mester, Ross Merrill, Vishnu Veeravalli, David A. Tice	1992	7
16	Importance of topical hypothermia to ensure uniform myocardial cooling during coronary artery bypass Journal of Thoracic and Cardiovascular Surgery ·R.W. Landymore, David A. Tice, Naresh Trehan, Frank C. Spencer	1981	48
17	Arterial and venous microsurgical bypass grafts for coronary artery disease Journal of Thoracic and Cardiovascular Surgery ·George E. Green, Frank C. Spencer, David A. Tice, Simon H. Stertzer	1970	51
18	Cloth-covered aortic and mitral valve prostheses Journal of Thoracic and Cardiovascular Surgery ·Frank C. Spencer, George E. Reed, Roy H. Clauss, David A. Tice, Edmund H. Reppert	1970	46
19	Chlorpromazine: Adjunct to physiologic perfusion Journal of Thoracic and Cardiovascular Surgery ·Ø ANGEN, David A. Tice, George E. Reed, Roy H. Clauss	1967	9
20	ASYMMETRIC EXAGGERATED MITRAL ANNULOPLASTY: REPAIR OF MITRAL INSUFFICIENCY WITH HEMODYNAMIC PREDICTABILITY Journal of Thoracic and Cardiovascular Surgery ·George E. Reed, David A. Tice, Roy H. Clauss	1965	85

About David A. Tice

David A. Tice is a scholar working on Immunology and Allergy, Cardiology and Cardiovascular Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Biochemistry, having authored 97 papers that have together received 4.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Cardiac Valve Diseases and Treatments (13 papers), HER2/EGFR in Cancer Research (12 papers), Cardiac and Coronary Surgery Techniques (9 papers), Cardiac Structural Anomalies and Repair (7 papers), Angiogenesis and VEGF in Cancer (7 papers), Infective Endocarditis Diagnosis and Management (7 papers) and Cell Adhesion Molecules Research (7 papers). The work is most often cited by research in Immunology and Allergy (390 citations), Oncology (1.4k citations), Cardiology and Cardiovascular Medicine (859 citations), Radiology, Nuclear Medicine and Imaging (748 citations) and Molecular Biology (1.9k citations). David A. Tice has collaborated with scholars based in United States, South Korea and Brazil. Frequent co-authors include Sarah J. Parsons, Jacqueline S. Biscardi, Frank C. Spencer, George E. Reed, Ming‐Chei Maa, Michael Cox, Roy H. Clauss, George E. Green, Paul Polakis and Weibo Cai. Their work appears in journals such as Cancer Research, Journal of Thoracic and Cardiovascular Surgery, Journal of Biological Chemistry, Circulation and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact